Early trial data and government refusal to approve the shot for over-65s, despite mounting evidence that it works well, have led to thousands of doses going unused. Source
Early trial data and government refusal to approve the shot for over-65s, despite mounting evidence that it works well, have led to thousands of doses going unused. Source